MedPath

Pulsed Electro Magnetic Fields (PEMF) in Depression

Not Applicable
Completed
Conditions
Depression, Unipolar
Interventions
Device: Treatment with PEMF equipment
Registration Number
NCT03556735
Lead Sponsor
University of Southern Denmark
Brief Summary

PEMF (Pulsed Electro Magnetic Fields) therapy has been used to stimulate bone repair in non-union since the 1970s. This is an accepted use, which has been approved by the Food and Drug Administration in the US. The mode of action of PEMF is based on creating small electrical fields in tissue and thereby promoting healing. Besides it has been shown that PEMF enhance regeneration of nerve fibers exposed to a lesion For treatment of depression the PEMF equipment, which are provided by the company Re5 A/S, consists of a 220 V impulse generator that creates electrical impulses and an applicator which consists of an electrical cable connected to a helmet on which there are 7 electrical coils on the inside. In comparison with the rTMS (Transcranial Magnetic Stimulation) equipment, which uses stimuli approaching neuronal firing level, the PEMF fields in human is very much lower.

Detailed Description

Applied to cells PEMF have a stimulatory effect on intracellular tyrosine kinase activity, especially the Src family. The Src family upregulate NMDAR (N-methyl-D-aspartate) subtype of glutamate receptor thereby gating the production of NMDAR-dependent synaptic potentiation that are vital for processes that underlie physiological and pathological plasticity in the brain. Dysregulation of fibroblast growth factor receptors in frontal cortical regions of the brain seem to be associated with depression. The fibroblast growth factors are highly dependent on the activity of the Src family.

For treatment of depression the PEMF equipment, which are provided by the company Re5 A/S, consists of a 220 V impulse generator that creates electrical impulses and an applicator which consists of an electrical cable connected to a helmet on which there are 7 electrical coils on the inside. In comparison with the rTMS equipment, which uses stimuli approaching neuronal firing level, the PEMF fields in human are very much lower.

PEMF treatment involves placing the treatment helmet on the head and connecting it to a power source (220 V), which leads to induction of a pulsating magnetic field. The treatment was given for 30 min once or twice daily for 8 weeks. Participants are awake during these treatments and sit in a chair where they can read or eat. Pilot data demonstrates that the treatment can give mild transient nausea. No other side effects have been observed.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
59
Inclusion Criteria
  • Treatment resistant depression is defined as treatment with at least two antidepressants from different classes in an optimal dose and with sufficient duration (at least 8 weeks).
  • A score on HamD17 above 17.
  • Antidepressant medication must not have been changed 4 weeks before inclusion.
Exclusion Criteria

A Ham-D17 item 3 at 2 or more (suicidal risk increased) A moderate manic condition (MAS-M above 14) The participant must not be under some sort of restrictions Pregnancy Severe personality disorders Psychotic mental disorders Brain diseases

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
PEMF treatmentTreatment with PEMF equipmentNo sham group (placebo) was chosen. Treatment consisted of one active group in a multicenter study.
Primary Outcome Measures
NameTimeMethod
Change in the Hamilton Depression Scale (HAM-D17)8 weeks

HamD17 scale

Secondary Outcome Measures
NameTimeMethod
Response and remission8 weeks

HamD17 scale

Life Quality8 weeks

WHO-5 scale

Side effects8 weeks

Prise scale

Trial Locations

Locations (1)

Department of Psychiatry, Psychiatry in the Region of Southern Denmark

🇩🇰

Odense, Region Of Southern Denmark, Denmark

© Copyright 2025. All Rights Reserved by MedPath